The clinivation Global xi enterprise solution for Market Clearance Management enables executives and their teams to address the challenges of execution, effective governance, and lean business performance in their global market clearance operations. By enabling excellence in global market clearance operations to advance the revenue intrinsic to market clearance success, clinivation Global xi liberates revenue that's trapped-in-process.

St. Jude Medical's Cardiac Rhythm Management Division designs, manufactures, and supports state-of-the-art devices to treat bradycardia (debilitating slow heartbeat), tachycardia (life-threatening fast heartbeat), and other cardiac rhythm disorders. St. Jude Medical- CRMD's global operations facilities are located in Sylmar and Sunnyvale, California; Scottsdale, Arizona; Pickens, South Carolina; and Veddesta, Sweden. At these sites the company carries out research and development activities and manufactures top-quality electrical stimulation products and product components: Pacesetter brand pacemakers to treat bradycardia, Ventritex brand implantable cardioverter defibrillators (ICDs) to control tachycardia, leads to connect pulse generators to the heart, programmers to communicate with the companies implanted devices, hybrid elements that constitute the "brains" of their pacemakers and ICDs, and unique capacitors for ICDs.

For more information, please visit www.sjm.com.

Clinivation is the leading provider of integrated solutions that enable global market clearance. Guided by our singular vision - "Excellence in Market Clearance" - clinivation accelerates the entire market clearance cycle to advance new worldwide revenue and achieve new milestones of enterprise value.

Used in over 1,000,000 product registrations by more than 100 companies worldwide, clinivation's end-to-end technology and services deliver on our vision by eliminating revenue traps from global market clearance operations, increasing process velocity with on-demand regulatory intelligence, automating clearance-driven business controls, simplifying content unification into market clearance applications, aligning quality systems with global market clearance priorities, streamlining clinical development with clearance-focused trials, and enabling management with key performance indicators for continuous improvement and effective governance.

The world's leading medical device, diagnostics, hospital supply, and dental supply companies select clinivation because of our medtech industry focus and our unique, integrated solutions that seamlessly adapt to existing business processes and enterprise infrastructure- without the need to write custom code.
Our core brands include the clinivation Global xi market clearance platform, clinivation WorldView on-demand regulatory intelligence, and clinivation Clinical Suite and clinivation Registry Suite electronic data capture and clinical data management software.

Founded in 1999, the company is headquartered in Natick, Massachusetts, with regional offices in North America and Asia.

Visit clinivation online at www.clinivation.com

For more information on clinivation's integrated solutions that enable global market clearance, please click here or call us at 508.655.6560.